1715 results for Treatments

Refine Your Search

FAQs: Proposed federal spending cuts and blood cancer research and care

FAQs: Proposed federal spending cuts and blood cancer research and care

The Leukemia & Lymphoma Society (LLS) has heard great concerns from patients, caregivers, volunteers, healthcare professionals, researchers, community…

News Release

A phase 2 trial of EO2463, a novel microbial-derived peptide therapeutic vaccine, as monotherapy, and in combination with lenalidomide and rituximab, for treatment of patients with indolent NHL

In October 2023, LLS made an equity investment in Enterome to "support the ongoing Phase 2 SIDNEY study of EO2463 in indolent non-Hodgkin B-cell lymph…

Fox Valley All Blood Cancers Group

Fox Valley All Blood Cancers Group

The group will address specific issues related to a blood cancer diagnosis and will provide an opportunity for attendees to discuss concerns, anxietie…

Immune-Onc Therapeutics Announces IO-202 Granted Fast Track Designation by FDA for the Treatment of Relapsed or Refractory CMML

PALO ALTO, CA, June 7, 2023 – Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a private, clinical-stage oncology company dedicated to the discovery and …

Leukemia vs. lymphoma: What you need to know

Leukemia vs. lymphoma: What you need to know

Table of contentsLeukemia vs. Lymphoma: What You Need to KnowWhat Is Leukemia?Organs Affected by LeukemiaWhat Is Lymphoma?Organs Affected by LymphomaD…

FDA Approves New Treatment Option for Patients with Relapsed or Refractory Large B-Cell Lymphoma

FDA Approves New Treatment Option for Patients with Relapsed or Refractory Large B-Cell Lymphoma

Rye Brook, NY, August 10, 2021 - The U.S. Food and Drug Administration (FDA) approved loncastuximab tesirine-lpyl (ZYNLONTA) to treat adult patients w…

News Release

Multiple Myeloma Patients Cancer Free Five Years after Single CAR-T Treatment

Multiple Myeloma Patients Cancer Free Five Years after Single CAR-T Treatment

LLS provided critical funding at earliest stages and provides ongoing CAR-T funding today June 9, 2025 – A new report is opening the possibility that …

News Release

Another CAR T -Cell Therapy Approved for Earlier Treatment of the Most Common Type of Lymphoma

Another CAR T -Cell Therapy Approved for Earlier Treatment of the Most Common Type of Lymphoma

The U.S. Food and Drug Administration (FDA) today approved CAR T-immunotherapy lisocabtagene maraleucel (Breyanzi®) for treatment of adults with large…

What’s Next in Blood Cancer: Looking Ahead to 2023

What’s Next in Blood Cancer: Looking Ahead to 2023

We’ve come a long way and we continue to make substantial progress. The outlook for blood cancer patients is better than ever, but it’s still nowhere …

LLS, advocates celebrate major state policy wins for patients

LLS, advocates celebrate major state policy wins for patients

While Congress meets year-round, state legislatures typically meet only in the first half of the year. The start of the summer generally marks the end…

A Source of Hope: Understanding Bone Marrow and Stem Cell Transplants

Imagine a community filled with families, friends, and healthcare professionals united to transform the meaning of living with blood cancer. This dive…

Videos for school personnel

Videos for school personnel

The following videos were created to assist school personnel in supporting a student attending school during or after cancer treatment, and their clas…

YAconnect: Young Adults Living with Leukemia, Lymphoma and Myeloma

Practicing Self-Advocacy During My PTCL Journey

Practicing Self-Advocacy During My PTCL Journey

The LLS Blog invites Aaron, who was diagnosed with peripheral T-cell lymphoma (PTCL), to share his reflections on becoming a self-advocate throughout …

Leading Treatment for Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma Now Available in Tablet Form

Leading Treatment for Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma Now Available in Tablet Form

WASHINGTON, (June 20, 2025) – The U.S. Food and Drug Administration has approved a new tablet formulation of zanubrutinib (Brukinsa®) which is used to…

News Release

A Day in LLS History

A Day in LLS History

On October 20, 1944, Robert “Robbie” Roesler de Villiers was only 16 years old when he died from leukemia. Robbie’s parents, Rudolph and Antoinette, w…

5 Ways to Support Blood Cancer Patients

Have you ever Googled, “what to do for someone with cancer”? Have you felt helpless or frustrated when trying to think of something meaningful to offe…

Understanding Myeloma: A Quick Guide

Myeloma is a rare blood cancerLet’s address the elephant in the room. Myeloma is not a skin cancer—that’s melanoma. And it’s not a bone cancer—althoug…

Heart Disease in Lymphoma Survivors

Heart Disease in Lymphoma Survivors

Matthew Matasar is a hematology and oncology specialist at Memorial Sloan-Kettering Cancer Center in New York City. He has a Translational Research Pr…

Communicating With Your Healthcare Team: Treatment

It’s important to communicate with your healthcare team once your treatment plan is in place. Maintaining good communication is as important as ever.

Chapter 4: The Healthcare Team and Treatment Center

Part of the The Caring for Kids And Adolescents with Blood Cancer workbook, which provides information for caregivers of child and adolescent patients.

Caregivers may order a copy of the full workbook by calling (800) 955-4572.

Dental and Oral Complications of Cancer Treatment

This fact sheet can help you understand the dental and oral complications of cancer treatment, and what you should do before and during treatment.

Diagnosed with a Blood Cancer? Important Questions You Might Not Think to Ask

Diagnosed with a Blood Cancer? Important Questions You Might Not Think to Ask

What is my actual diagnosis? Find out your exact diagnosis. Ask your doctor to write down the exact name of your sub-type and take the paper with you.…

Disease- and Treatment-Related Pain

People with cancer can have pain caused by the cancer itself, its treatment, or both. They may also have pain caused by other health problems that are…

Chronic Myeloid Leukemia (CML): Current Strategies & Insights

Join us for a free webinar covering the latest information for patients and caregivers.To register by phone, call (866) 992-9950.Topics CoveredWe invi…